Keywords: Encapsulin nanocompartments; Surface display; Cargo encapsulation; Protein-based nanoparticle carrier; Rational vaccine design; T. maritima; Thermotoga maritima; E. coli; Escherichia coli; GFP; Green Fluorescence Protein; M2e; Matrix2 protein ectodomain;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Baculovirus; Hand-foot-and-mouth disease; VLP; Vaccine; EV-A71; CV-A16;
Keywords: BSA; bovine serum albumin; CL; cardiolipin; Dd; dodecahedron; ECL; enhanced chemiluminescence; FBS; fetal bovine serum; GUV; giant unilamellar vesicle; HAd3; human adenovirus serotype 3; HRP; horseradish peroxidase; HSPG; heparan sulphate proteoglycan; LU
Keywords: 5-FU; 5-fluoro-uracil; AAV; adeno-associated virus; ADAM; ADAM metallopeptidase domain; ADCC; antibody-dependent cell-mediated cytotoxicity; CCL; chemokine (C-C motif) ligand; CD; cluster of differentiation; CTLA-4; cytotoxic T-lymphocyte-associated ant
Keywords: AN; anterior thalamic nuclei; IML; internal medullary lamina; MD; mediodorsal nuclei; MTT; mammillothalamic tract; VA; ventral anterior nucleus; VAmc; magnocellular ventral anterior nucleus; Vim; ventral intermediate nucleus; VLa; ventral lateral anterior
Keywords: West Nile virus; Pseudo-infectious virus; Reporter virus; BSL-3; Antiviral screening; WNV; West Nile virus; DENV; dengue virus; YFV; yellow fever virus; JEV; Japanese encephalitis virus; BSL-3; biosafety level-3; VLP; virus like particle; MOI; multiplicit
Keywords: CP; capsid protein; CSVB5; Coxsackie virus B5; Cterminus; carboxyl-terminus; DMEM; Dulbecco's modified Eagle medium; ECL; enhanced chemiluminescence; iELISA; indirect enzyme-linked immunosorbent assay; IFA; immunofluorescence assay; KLH; keyhole limpet
Keywords: BEM; boundary element method; CI; confidence interval; CSD; cross-spectral density; DBS; Deep Brain Stimulation; DICS; Dynamic Imaging of Coherent Sources; DPSS; discrete prolate spheroidal sequences; EDC; Musculus extensor digitorum communis; EMG; Electr
Keywords: Recombinant vaccines; virus-like particles; culture mode; immunogen; production platform; VLP; virus-like particle; B/IC; baculovirus-insect cell expression system;
Recent advances in click chemistry reactions mediated by transition metal based systems
Keywords: AOC; azide-olefin cycloaddition; APSiO2; 3-aminopropyl-functionalized silica; AscNa; sodium ascorbate; aterpy; 4â²-azido-2,2â²:6â²,2â³-terpyridine; bipy; 4,4â²-bipyridine; BMIM BF4; 1-butyl-3-methylimidazolium tetrafluoroborate; bpoh; (N1E,N2E)-N1,N2
Keywords: VNP; viral nanoparticle; VLP; virus-like particle; CP; coat protein; TR; thrombin receptor; VEGFR-3; Vascular Endothelial Growth Factor 3; TuMV; Turnip mosaic virus; Viral nanoparticles; Peptide presentation; Thrombin receptor peptide; Antibody sensing; V
Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis
Keywords: BGE; background electrolyte; BSA; bovine serum albumin; HPV; human papillomavirus; OPD; O-phenylenediamine dihydrochloride; PBS; phosphate buffered saline; PEO; poly(ethylene oxide); VLP; virus-like particles; Papillomavirus; Capillary electrophoresis; Qu
Keywords: IBD; inflammatory bowel diseases; GI tract; gastrointestinal tract; UC; ulcerative colitis; CD; Crohn's disease; GWAS; genome-wide association study; SNP; single-nucleotide polymorphism; NADPH; nicotinamide adenine dinucleotide phosphate; MDP; muramyl dip
Keywords: APC; antigen-presenting cell; BMA; butyl methacrylate; C16; 2-(R/S)-hexadecanoic acid; (C18)2; N,N-dioctadecyl succinamic acid; CFA; complete Freund's adjuvant; CuAAC; copper-catalyzed azide-alkyne cycloaddition; DLS; dynamic light scattering; ELISA; enzy
Keywords: APC; antigen presenting cells; CSP; circumsporozoite protein; DHF; dengue haemorrhagic fever; DSS; dengue shock syndrome; GMP; good manufacturing practices; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HIV; human immunodeficiency virus; HPV
Keywords: African horse sickness virus; AHSV; Core-like particles; Virus-like particles; VLP
Keywords: Virus-like particle; VLP; Sucrose cushion; Nycodenz gradient; Purification; Molecular farming;
Keywords: Enterovirus 71; Virus-like particles; VLP; Vaccine; Immunogenicity;
Keywords: Dromedary camel HEV; Recombinant baculovirus; Virus-like particles; VLP; Insect cells Tn5
Keywords: VLP; Aqueous two-phase systems; Centrifugal partition chromatography; High-throughput screening; DNA removal; Parvovirus;
Keywords: Human bocaviruses; HBoV1-4; Recombinant baculovirus; Virus-like particles; VLP; Insect cells Tn5 and Sf9;
Keywords: HCMV; human cytomegalovirus; ORF; open reading frame; SOT; solid organ transplant; HSCT; hematopoietic stem cell transplant; Râ/D+; a HCMV seronegative recipient with SOT from a seropositive donor; MVV; modified virus vaccine; IAV; individual antigen va
Keywords: AAV; adeno-associated virus; CTF; contrast transfer function; EM; electron microscopy; FSC; Fourier shell correlation; HBD; heparin-binding domain; HSPG; heparan sulfate proteoglycan; VLP; virus-like particle; Difference map; Refinement; Parvovirus; Recep
Keywords: Virus-like particle; VLP; Influenza; Receptor; Biomolecular engineering; Modular;
Keywords: Virus-like particle; Influenza vaccine; M1 immunodominant epitopes; Adenoviral dodecahedron; Cell-mediated immunity; aa; amino acid; Ad; adenovirus; Ad3; adenovirus serotype 3; APC; antigen-presenting cells; CTL; cytotoxic T lymphocyte; Dd; dodecahedron;
Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli
Keywords: Malaria; Plasmodium; Particle-based vaccine; Solubility tag; Bacterial protein expression; Tetrahymena; EPA; ExoProtein A; Grl1p; granule lattice protein 1; G-SOME; self-assembling Grl particle; SMFA; standard membrane feeding assay; TBV; transmission-blo
Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay
Keywords: ALT; alanine aminotransferase; BSA; bovine serum albumin; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; G3; genotype 3; HBV; hepatitis B virus; HCV; hepatitis C virus; HEV; hepatitis E virus; HIV; human immunodeficiency virus; HEV-Ag;
High-level expression and immunogenicity of porcine circovirus type 2b capsid protein without nuclear localization signal expressed in Hansenula polymorpha
Keywords: Porcine circovirus type 2b; Nuclear localization signal; Hansenula polymorpha; Immunogenicity; Purification; H.polymorpha; Hansenula polymorpha; PCV2b; Porcine circovirus type 2b; NLS; Nuclear localization signal; CP; Capsid protein; VLP; Virus like parti
Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone
Keywords: Influenza; Vaccine; H5N1; VLP; Propiolactone;
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14â¯years: Results to month 36 from a randomized trial
Keywords: 2D; 2-dose; 3D; 3-dose; AAHS; aluminum hydroxyphosphate sulphate; AE; adverse event; ANOVA; analysis of variance; AS04; Adjuvant System containing 50 µg 3-O-desacyl-4â²-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al3+); ATP; accordin
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses
Keywords: Adenovirus; pIX; Human papillomavirus; Minor capsid protein; Vaccine; a.a; amino acid; AdV; adenoviral; HAdV35; human adenovirus 35; HPV; human papillomavirus; MSD; Meso Scale Discovery; nAb; neutralizing antibody; pIX; protein IX; VLP; virus-like particl
Modular MLV-VLPs co-displaying ovalbumin peptides and GM-CSF effectively induce expansion of CD11b+ APC and antigen-specific T cell responses in vitro
Keywords: GM-CSF; granulocyte macrophage-colony stimulating factor; MLV; Murine Leukemia Virus; VLP; virus-like particle; OVA; ovalbumin; DC; dendritic cell; APC; antigen-presenting cell; MOP; multiplicity of particles; HPV; Human Papillomavirus; Modular vaccines;
Biomedical Applications of Lumazine Synthase
Keywords: lumazine synthase; stability; vaccine; polyvalent antigen display; immunogenicity; virus-like particle; drug delivery; adjuvant; LS; Lumazine synthase; BsLS; Lumazine synthase from Bacillus subtilis; AaLS; Lumazine synthase from Aquifex aeolicus; BspLS; L
Treating insect-bite hypersensitivity in horses with active vaccination against IL-5
Keywords: Allergic dermatitis; eosinophils; vaccination; CMV; Cucumber mosaic virus; CMVTT; Cucumber mosaic virus containing the tetanus toxoid universal T-cell epitope tt830-843; eIL-5; Equine IL-5; HRP; Horseradish peroxidase; IBH; Insect-bite hypersensitivity; I
Asymmetrical flow field-flow fractionation in purification of an enveloped bacteriophage Ï6
Keywords: AF4; asymmetrical flow field-flow fractionation; BSA; bovine serum albumin; CIM; convective interaction media; Dgeo; geometric diameter; DLS; dynamic light scattering; ds; double stranded; MALS; multi angle light scattering; MWCO; molecular weight cut-off
Conservation and variation of the hepatitis E virus ORF2 capsid protein
Keywords: HEV; hepatitis E virus; ORF; open reading frames; AA; amino acid; ICTV; International Committee on Taxonomy of Virus; PDB; Protein Data Bank; RMSD; root mean square deviation; VLP; virus-like particles; mAb; monoclonal antibody; MW; molecular weight; NCBI
Molecular imprinting technology for microorganism analysis
Keywords: Analytical detection; Identification; Microorganism; Molecular imprinting; Biosensor; AFM; Atomic force microscopy; B. subtilis; Bacillus subtilis; CV; Cyclic voltammetry; CFU; Colony-forming units; D. radiodurans; Deinococcus radiodurans; E. coli; Esc
Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine
Keywords: Bovine papillomavirus; L1 protein; Capsomeres; VLP; Vaccine; Biosafety; BP; Bovine papillomatosis; BPV; Bovine papillomavirus; CBMNT; Cytokinesis-block micronucleus test; ELISA; Enzyme-linked immunosorbent assay; HPV; Human papillomavirus; OPD; O-Phenylen
Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease
Keywords: i.n.; intranasal; i.m.; intramuscular; VLP; virus-like particle; SeV; Sendai virus; NW; nasal wash; BAL; bronchoalveolar lavage; SCD; sickle cell disease; HET; control, heterozygous mice; DPBS; Dulbecco's phosphate-buffered saline; Parvovirus B19 vaccin
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants
Keywords: Plasmodium falciparum; Malaria; Vaccine; Nanoparticle; Adjuvant; Scale-up; 3D-PHAD; 3-deacyl monophosphoryl lipid A; ALF; Army Liposomal Formulation; CSP; Circumsporozoite protein; DPMC; 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPMG; 1,2-dimyristoyl-s
Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens
Keywords: Influenza; Avian flu; Vaccine; Recombinant; Virus-like particle; VLP;
Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines
Keywords: Influenza; H5N1; Universal vaccine; VLP; Oil-in-water adjuvant;
C-terminal domain on the outer surface of the Macrobrachium rosenbergii nodavirus capsid is required for Sf9 cell binding and internalization
Keywords: Shrimp; Nodavirus; Virus-host interaction; Internalization; VLP;
In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses
Keywords: Heterologous prime-boost vaccination; In vivo electroporation; HIV-1; IgG subclasses; Neutralizing antibody; T cell responses; EP; electroporation; DDVV; priming twice with DNA plasmids and boosting twice with HIV-1 VLP; VLP; virus-like particles; RB; rec
Major findings and recent advances in virus-like particle (VLP)-based vaccines
Keywords: VLP; virus-like particle; CCMV; cowpea chlorotic mottle virus; HBV; hepatitis B virus; PASP; pathogen associated structural pattern; BCR; B cell receptor; APC; antigen presenting cell; LN; lymph node; SCS; sub capsular sinus; DC; dendritic cell; cDC; conv
Potential of RNAi applications to control viral diseases of farmed shrimp
Keywords: dsRNA; double-stranded RNA(s); VLP; viral-like particle(s); dsRNA; Penaeid shrimp; Viral infection; White spot syndrome virus; RNAi;
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials
Keywords: HPV; human papillomavirus; VLP; virus-like particle; 9vHPV; 9-valent human papillomavirus; cLIA; competitive Luminex immunoassay; GMTs; geometric mean titers; CI; confidence interval; mMU/mL; milli-Merck units per milliliter; qHPV; quadrivalent human papi
Recurrent emergence of structural variants of LTR retrotransposon CsRn1 evolving novel expression strategy and their selective expansion in a carcinogenic liver fluke, Clonorchis sinensis
Keywords: DDH; DNA-DNA hybridization; IN; integrase; IRAP; inter-retrotransposon amplified polymorphism; LINE; long interspersed nuclear element; LTR; long terminal repeat; ORF; open reading frame; PR; protease; RH; RNase H; RT; reverse transcriptase; SINE; short
Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction
Keywords: HIV-1; Env, trimer; Gp120, neutralization; Vaccine; VLP; Antibody; Glycan;
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis
Keywords: PDCD1; Immune Regulation; Response To Treatment; Liver Disease; BAFF; B-cell-activating factor of the tumor necrosis factor family; BR3; B-lymphocyte stimulator receptor 3; CV; cryoglobulinemia vasculitis; DAA; direct-acting antiviral; EOT; end of treat